Pentylenetetrazol-induced seizures in rats: an ontogenetic study

L Velisek1, H Kubova, M Pohl

  • 1Institute of Physiology, Czechoslovak Academy of Sciences, Prague.

Insights

Pentylenetetrazol (PTZ) reliably induced minimal motor seizures in rats from 18 days old. Major seizures occurred at all ages, with dose-response variations observed in 18-day-old and adult rats.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Developmental Biology

Background:

  • Pentylenetetrazol (PTZ) is a convulsant used to study seizure mechanisms.
  • Understanding age-dependent seizure susceptibility is crucial for neurological research.

Purpose of the Study:

  • To quantitatively describe motor seizures induced by PTZ in rats across different developmental stages.
  • To analyze age-related differences in PTZ-induced seizure patterns and their lethal dose 50 (CD50).

Main Methods:

  • Administered varying doses of PTZ (40-120 mg/kg) subcutaneously to 477 male Wistar rats aged 7 to 90 days.
  • Observed and categorized two seizure patterns: minimal (facial/forelimb clonus) and major (generalized tonic-clonic).
  • Determined the CD50 for both seizure types across different age groups.

Main Results:

  • Minimal PTZ-induced seizures were consistently observed from 18 days of age, with no significant age-related change in CD50.
  • Major PTZ-induced seizures occurred at all studied ages.
  • The CD50 for major seizures showed no significant difference in 7-, 12-, and 25-day-old rats, but was lower in 18-day-old rats and higher in adult rats.

Conclusions:

  • Rat pups exhibit distinct developmental trajectories in their susceptibility to different types of PTZ-induced seizures.
  • Age significantly influences the dose required to elicit major seizures, with a notable increase in susceptibility in adulthood.